Neck Pain

Torticollis Treatment Market Size, Growth Trends, Top Players, Application Potential and Forecast to 2028 – The UB Post

Published

3 years ago

February 19, 2022

Torticollis Treatment Market research report survey thoroughly analyses the market using a team of industry experts, dynamic analysts, adept forecasters, and well-informed researchers. With this report, businesses can accomplish unrivaled insights and association of the best market opportunities into their respective markets. The market study carried out in this report analyzes the market status, market share, growth rate, future trends, market drivers, opportunities, and challenges, along with the risks and entry barriers, sales channels, and distributors in this industry.

Torticollis treatment marketis expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.60% in the above mentioned forecast period.

Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=Global-Torticollis-Treatment-Market

Torticollis Treatment Market Scenario:

Torticollis is a condition in which the muscles of the neck flex extend, or twist beyond their normal range of motion. Torticollis is defined as twisted neck in Latin. Torticollis is a condition in which the neck twists to one side, causing a head tilt. If you have a family history of the disorder, it can develop slowly, or it can develop quickly as a result of trauma or a drug reaction. This is a condition that can be passed down through generations. It is also possible for it to develop in the womb. If your baby’s head is in the improper posture, this can happen. It could also be caused by damage to the neck’s muscles or blood supply. Torticollis is also known as wry neck or loxia.

The rise in the number of cases of neck muscle injury during birth and burn injury is the major driver resulting in the expansion of market’s growth. Another significant factor influencing the growth rate of torticollis treatment market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, growing government funding and rising initiatives by public and private organisations to spread awareness are the factors that will expand the torticollis treatment market. Other factors such as increase in the incidences of bacterial or viral infection and changing lifestyle will positively impact the torticollis treatment market’s growth rate. Additionally, high prevalence of arthritis of cervical spine and upsurge in the adoption rate of early genetic counseling will cushion the growth rate of torticollis treatment market.

Moreover, the rise in the research and development activities and high unmet need of current treatment will provide beneficial opportunities for the torticollis treatment market in the forecast period of 2022-2029. Also, developments in the healthcare technology and emerging new markets will escalate the growth rate torticollis treatment market in future.

However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of torticollis treatment market. Additionally, complications involved with torticollis treatment such as muscle swelling, deformity of face and flat head syndrome, among others will hinder the torticollis treatment market growth. Less awareness will further challenge the market in the forecast period mentioned above.

This torticollis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the torticollis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Scope of Report:

Torticollis Treatment Marketbusiness report, it becomes easy to figure out types of consumers, their views about the product, their buying intentions and their ideas for advancement of a product. To get hold of knowledge of all the above factors, this transparent, wide-ranging and supreme market report is generated. And for this, the report also covers all the major topics of the market research analysis that includes market definition, market segmentation, competitive analysis, major developments in the market, and admirable research methodology. A consistent this report has been framed with the vigilant efforts of innovative and experienced team of analysts, researchers, industry experts, and forecasters. This report also encompasses all the information including market definition, classifications, key developments, applications, and engagements along with the detailed actions of key players with respect to product launches, joint ventures, developments, mergers and acquisitions and effects of the same in terms of sales, import, export, revenue and CAGR values.

To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-torticollis-treatment-market

TOP KEY PLAYERS of Torticollis Treatment Market

Some of the major players operating in the torticollis treatment market are Allergan, AbbVie Inc., GALDERMA, Evolus, Inc., Revance, HUGEL, Inc., Ipsen Pharma,USWM, LLC., Sun Pharmaceutical Industries Ltd., Pfizer Inc., GlaxoSmithKline plc, Merz Pharma, Medytox, Smith+Nephew, Sanofi, Novartis AG, Teva Pharmaceutical Industries Ltd., LGM Pharma., Lannett, NorthStar Rx LLC, and Par Pharmaceutical, among others.

Global Torticollis Treatment Market Scope and Market Size

The torticollis treatment market is segmented on the basis of type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

On the basis of type, the torticollis treatment market is segmented into temporary torticollis, muscular torticollis, klippel-feil syndrome, fixed torticollis, and cervical dystonia.

On the basis of treatment, the torticollis treatment market is segmented into medication, surgery, physical therapy and others. The medication segment is further sub-segmented into botulinum and baclofen.

On the basis of diagnosis, the torticollis treatment market is segmented into x-ray, computed tomography (CT) scan, magnetic resonance imaging (MRI), ultrasound, cervical spine examination, blood tests, electromyogram (EMG) and others.

On the basis of symptoms, the torticollis treatment market is segmented into limited movement of head, headache, head tremor, neck pain, shoulder that is higher than the other, stiffness of the neck muscles, swelling of the neck muscles and others.

On the basis of dosage, the torticollis treatment market is segmented into injection, tablets and others.

On the basis of route of administration, the torticollis treatment market is segmented into oral, parenteral and others.

On the basis of end-users, the torticollis treatment market is segmented into clinic, hospital and others.

The torticollis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Torticollis Treatment Market Country Level Analysis

Torticollis treatment market is analyzed and market size information is provided by the country, type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the torticollis treatment market reportare the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the torticollis treatment market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Complete Report Details with Table of Content and Figures@ https://www.databridgemarketresearch.com/toc/?dbmr=Global-Torticollis-Treatment-Market

Attaining knowledgeable information about the trends and opportunities in the industry is quite a time-consuming process. However, an international market research report cracks this problem very quickly and easily. This market report has been structured by thoroughly comprehending the specific needs of the business. The report precisely collects the data and information about valuable factors for this industry which range from customer behavior, emerging trends, product usage, and brand positioning. The information of the winning report not only helps businesses craft data-driven decisions but also assures maximum return on investment (ROI).

Highlights of this Study Market Research Report:
1. To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders
2. To describe and forecast the market, in terms of value, for various segments, by region North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW)
3. Key parameters which are driving this market and restraining its growth
4. What all challenges manufacturers will face as well as new opportunities and threats faced by them.
5. Learn about the market strategies that are being adopted by your competitors and leading organizations

Some of the key questions answered in this report:
● Detailed Overview of this Market helps deliver clients and businesses making strategies.
● Influential factors that are thriving demand and constraints in the market.
● What is the market concentration? Is it fragmented or highly concentrated?
● What trends, challenges and barriers will impact the development and sizing of this Market?
● SWOT Analysis of each key players mentioned along with its company profile with the help of Porter’s five forces tool mechanism to compliment the same.
● What growth momentum or acceleration market carries during the forecast period?

Top DBMR Healthcare Reports:

https://www.marketwatch.com/press-release/cyclophilin-inhibitors-therapeutics-market-share-application-analysis-regional-outlook-competitive-strategies-forecast-up-to-2028-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/fitness-app-market-share-worldwide-industry-growth-size-statistics-opportunities-forecasts-up-to-2028-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/dental-imaging-x-ray-market-size-share-and-forecast-2021-2028-north-america-expected-to-have-the-major-market-share-globally-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/nursing-education-market-size-share-and-forecast-2028-segmentation-key-insights-and-company-profiles-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/insufflation-needles-market-size-share-industry-growth-analysis-segmentation-overview-and-forecast-till-2028-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/nephropathic-cystinosis-treatment-market-2021-outlook-growth-by-top-companies-regions-types-applications-drivers-trends-forecasts-by-2028-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/facial-fat-transfer-market-trends-analysis-top-manufacturers-shares-growth-opportunities-statistics-forecast-to-2028-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/pain-management-therapeutics-market-outlook-strategies-manufacturers-countries-type-and-application-global-forecast-to-2028-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/respiratory-inhalers-market-2021-outlook-growth-by-top-companies-regions-types-applications-drivers-trends-forecasts-by-2028-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/north-america-excipients-market-global-industry-analysis-competitive-insight-and-key-drivers-research-report-2021-2028-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/middle-east-and-africa-neuroendocrine-tumors-market-global-market-estimation-dynamics-regional-share-trends-competitor-analysis-to-2028-2022-02-14?mod=search_headline

https://www.marketwatch.com/press-release/drug-addiction-treatement-market-forecast-2021-2028-by-regions-type-and-application-with-sales-and-revenue-analysis-2022-02-14?mod=search_headline

AmericanChiro

We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.

Neck Pain

Re: Chronic Pain: Management focuses on the individual, not the pain.

Published

2 years ago

July 17, 2023

AmericanChiro

Dear Editor

Chronic pain management focuses on the individual, not the pain.

I am very pleased with the review by Kang and colleagues [1]. I write as a spinal pain specialist whose patients had an average episode duration of pain pain of 2.5 years [2] for low back pain and 1.3 years for neck pain [3]. These studies confirm that Kang et. al. noted the significant extent of spinal and extraspinal pain, sleep disturbance, and psychological distress. I also recognize the ‘heartsinks’ who have seen many consultants for a variety of complaints, and those with hypersensitivity. I do accept that some patients need further investigations, but it can be done in a way that does not cause further anxiety. To ensure that intensive rehabilitation is not contraindicated. By showing a genuine interest in the family, job and interests of the individual, you can begin to build confidence and hope for the clinical path being recommended.

The review ignores trauma’s effects on some people, causing their pain to begin, and for others, a major factor. Thirteen percent of patients with neck pain who presented to my clinics had a traumatic origin with a missed break and significant psychological comorbidity. Subsequently, it became clear that post-traumatic distress (PTPD), [a term used because post-traumatic stress may require specialist knowledge for diagnosis] can be present in rheumatological practices [4] and with the increasing influx of refugees in the UK [5], more patients are being diagnosed with PTPD. This can have major effects on families [5]. PTPD is commonly seen in medicolegal situations where accidents have caused major destruction to the lives of individuals and their families, including divorce [6]; and is often associated mood disturbances [6].

Kang et. al. correctly mention that sleep disorders are important in the management chronic pain [1], however, two important aspects of a’sleep story’ must be identified. It is important to ask the individual what they are thinking about when they lie awake in bed at night. This may provide clues as to social or family stress. Second, you should ask about their nightmares and dreams, especially if they are unpleasant. These often involve reliving trauma or accidents. When asked about nightmares, people who deny any unpleasant memories during direct questioning may reveal clues. The presence of PTPD can be important because it opens up therapeutic opportunities with psychological support and medications.

My experience in rehabilitation medicine over the years has taught me that to fully assist our disadvantaged clients, social issues must be resolved before psychological issues, and psychological issues must be resolved before physical issues!

References

1. Kang Y et. al., Chronic Pain: Definitions and Diagnosis. BMJ (Clinical Research ed. ), 2023. 381: p. e076036.

2. Frank A. et al. A cross-sectional study of the clinical and psychosocial features of low back injury and the resulting work handicap: Use of the Quebec Task Force Classification. Int J Clin Pract, 2000; 54(10) p. 639-644.

3. Frank A, De Souza L and Frank C. Neck Pain and Disability: A Cross-sectional Survey of the Demographic and Clinical Characteristics of Neck Pain Seen in a Rheumatology Clinic. Int J Clin Pract 2005; 59(doi: 10.1111/j.1742-1241.2004.00237.x): p. 173-182.

4. McCarthy J. and Frank A. Posttraumatic psychological distress can present in rheumatology. BMJ 2002. 325(27 July): p. 221-221.

5. Frank A. Refugee status: a yellow-flag in managing back pain. BMJ 2007;334(13 Jan): p.58-58.

6. Frank A. Psychiatric effects of road traffic accidents: often disabling, and not recognised (letter). BMJ 1993, 307(13th Nov): p.1283.

AmericanChiro

We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.

Neck Pain

Landmark Trial: Opioids No Better Than Placebo for Back Pain

Published

2 years ago

July 16, 2023

AmericanChiro

The first randomized controlled study testing the efficacy of a short course opioids for acute nonspecific neck/low back pain suggests that opioids do not relieve acute neck or low back pain in the short-term and can lead to worse outcomes over the long-term.

After 6 weeks there was no significant difference between the pain scores of patients taking opioids and those who took a placebo. After one year, the pain scores of patients who received placebos were slightly lower. After 1 year, opioid users were also at a higher risk of opioid abuse.

Senior author Christine Lin, Ph.D., from the University of Sydney told Medscape Medical News that this is a “landmark trial” with “practice changing” results.

Lin explained that “we did not have any good evidence before this trial on whether opioids are effective for acute neck or low back pain, but opioids are one of the most commonly prescribed medicines for these conditions.”

Lin stated that based on these results “opioids shouldn’t be recommended at any time for acute neck and low back pain,”

The results of the OPAL study have been published online in The Lancet on June 28.

Rigorous Test

The trial was conducted at 157 primary care and emergency departments in Australia, with 347 adults who experienced low back pain or neck pain for 12 weeks or less.

They were randomly allocated (1:1) to receive guideline-recommended care (reassurance and advice to stay active) plus an opioid (oxycodone up to 20 mg daily) or identical placebo for up to 6 weeks. Naloxone is given to prevent opioid-induced constipation, and to improve blinding.

The primary outcome was the pain severity at six weeks, as measured by the pain severity subscale (10-point scale) of the Brief Pain Inventory.

After 6 weeks of opioid therapy, there was no difference between placebo and opioid therapy in terms of pain relief or functional improvement.

The mean pain score was 2.78 for the opioid group at 6 weeks, compared to 2.25 for the placebo group. (Adjusted median difference, 0.53, 95% CI -0.00 – 1.07, P=.051). At 1 year, the mean pain scores of the placebo group were lower than those of the opioid group (1.8 and 2.4).

The risk of opioid misuse was doubled at 1 year for patients randomly assigned to receive opioid therapy during 6 weeks as compared to those randomly assigned to receive placebo during 6 weeks.

At 1 year, the Current Opioid Use Measure (COMM), a scale that measures current drug-related behavior, indicated that 24 (20%) patients from 123 patients who received opioids, were at risk for misuse. This was compared to 13 (10%) patients from 128 patients in a placebo group ( p =.049). The COMM is a widely-used measure of current aberrant drug related behavior among chronic pain patients who are prescribed opioid therapy.

Results Raise “Serious Questions”

Lin told Medscape Medical News that “I think the findings of the research will need to be distributed to doctors and patients so they receive the latest evidence on opioids.”

“We must reassure doctors and their patients that the majority of people with acute neck and low back pain recover well over time (normally within 6 weeks). Therefore, management is simple – stay active, avoid bed rest and, if needed, use a heat pack to relieve short term pain. Consider anti-inflammatory drugs if drugs are needed,” Lin added.

The authors of the linked comment state that the OPAL trial raises serious questions regarding the use of opioids for acute neck and low back pain.

Mark Sullivan, MD PhD, and Jane Ballantyne MD, from the University of Washington in Seattle, note that clinical guidelines recommend opioids to patients with acute neck and back pain when other drugs fail or are contraindicated.

As many as two thirds of patients may receive an opioid for back or neck pain. Sullivan and Ballantyne say that it is time to reexamine these guidelines.

The National Health and Medical Research Council (NHMRC), the University of Sydney Faculty of Medicine and Health (University of Sydney Faculty of Medicine and Health) and SafeWork SA funded the OPAL study. The authors of the study have not disclosed any relevant financial relationships. Sullivan and Ballantyne have served as board members of Physicians for Responsible Opioid Prescribing (unpaid), and paid consultants for opioid litigation.

Lancet. Online published June 28, 2023. Abstract

Join us on Facebook or Twitter for more Medscape Neurology News.

AmericanChiro

We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.

Neck Pain

‘I tried acupuncture for back and neck pain even though I’m afraid of needles–and it’s literally the only thing that’s ever worked’

Published

2 years ago

July 15, 2023

AmericanChiro

To view this content, you must be logged-in as a subscriber.

4 WEEKS

$10

52 WEEKS

$130

Day Pass

$2.99

All plans include full website access and exclusive online extras.

Plans available in both print and digital formats

ALREADY a print subscriber?

AmericanChiro

We understand how important it is to choose a chiropractor that is right for you. It is our belief that educating our patients is a very important part of the success we see in our offices.